AxoGen Inc AXGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
20.30UNCH (UNCH)
Volume
4,283
Close
20.30quote price arrow up+0.37 (+1.86%)
Volume
313,794
52 week range
7.16 - 22.89

...

Loading . . .

KEY STATS

  • Open20.06
  • Day High20.39
  • Day Low18.70
  • Prev Close19.93
  • 52 Week High22.89
  • 52 Week High Date02/23/21
  • 52 Week Low7.16
  • 52 Week Low Date04/16/20
  • Market Cap827.02M
  • Shares Out40.74M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • 1 Year % Change67.08

RATIOS/PROFITABILITY

  • EPS (TTM)-0.60
  • P/E (TTM)-34.05
  • Fwd P/E (NTM)-40.20
  • EBITDA (MRQ)-21.501M
  • ROE (MRQ)-18.63%
  • Revenue (MRQ)112.30M
  • Gross Margin (MRQ)78.75%
  • Net Margin (MRQ)-21.18%
  • Debt To Equity (MRQ)26.03%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest AxoGen Inc News

There is no recent news for this security.

Latest AXGN News From Our Partners

QUOTE FINDER

Profile

MORE
AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along with these core surgical products, the Company also offers the AxoTouch Two-Point Discriminator, and AcroVal Neurosensory and Motor Testing System....
Karen Zaderej
Chairman
Peter Mariani CPA
Chief Financial Officer
Erick DeVinney
Vice President
Mark Friedman Ph.D.
Vice President
Address
13631 Progress Blvd Ste 400
Alachua, FL
32615-9409
United States